Displaying 441 - 460 of 2209
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson
FTC Announces Tentative Agenda for June 16 Open Commission Meeting
Statement of Chair Lina M. Khan Regarding 6(b) Study of Pharmacy Benefit Managers
Concurring Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding 6(b) Study of Pharmacy Benefit Managers
Statement of Commissioner Rebecca Kelly Slaughter Regarding 6(b) Study of Pharmacy Benefit Managers
FTC Sues to Block Merger Between Utah Healthcare Rivals HCA Healthcare and Steward Health Care System
FTC Acts to Protect South Carolina and Alabama Markets from Anticompetitive Gasoline Terminal Deal
FTC Sues to Block Merger Between New Jersey Healthcare Rivals RWJBarnabas Health and Saint Peter’s Healthcare System
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson in the Matter of Buckeye Partners/Magellan Midstream Partners
FTC and Justice Department to Hold Two-Day Virtual Public Workshop Examining Antitrust Enforcement in the Pharmaceutical Industry
Written Submission on the Public Interest of Chair Lina M. Khan and Commissioner Rebecca Kelly Slaughter in the Matter of Certain UMTS and LTE Cellular Communication Modules
Alvaro Bedoya Sworn in as FTC Commissioner
FTC Acts to Protect Patients Who Rely on Medical Instruments Used in Sinus Procedures
FTC Requires Prince and Ferro to Sell Off Three Facilities amid Concerns that Deal would Increase Concentration in North American Market for Porcelain Enamel Frit
Clarence L. Werner, U.S. v.
Clarence L. Werner, founder of the Omaha, Nebraska-based truckload carrier Werner Enterprises, Inc. will pay a $486,900 civil penalty to settle charges that certain of his acquisitions of company stock while he was a director of the company violated the Hart-Scott-Rodino Act. The HSR Act requires companies and individuals to report stock purchases over a certain threshold to the FTC and DOJ and wait before closing the transaction so that the federal agencies can investigate the potential competitive impact of the acquisition. Smaller transactions may also be reportable under the Act due to the need to aggregate the new purchase with all current holdings.
Federal Trade Commission Preserves Competition for Development and Marketing of Steroid Injectable Drug
Statement Regarding Texas Jury’s Verdict that Former Owner Neeraj Jindal Obstructed FTC’s Antitrust Investigation into Physical Therapy Staffing Company
FTC Approves Final Order Prohibiting Louisiana Real Estate Appraisers Board from Fixing Prices for Appraisal Services in Louisiana
Displaying 441 - 460 of 2209